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Phosphorylation of the NR1 subunit of NMDA receptors (NMDARs) at serine (S) 897 is markedly reduced in schizophrenia patients.
However, the role of NR1 S897 phosphorylation in normal synaptic function and adaptive behaviors are unknown. To address these
questions, we generated mice in which the NR1 S897 is replaced with alanine (A). This knock-in mutation causes severe impairment in
NMDAR synaptic incorporation andNMDAR-mediated synaptic transmission. Furthermore, the phosphomutant animals have reduced
AMPA receptor (AMPAR)-mediated synaptic transmission, decreased AMPAR GluR1 subunit in the synapse, and impaired long-term
potentiation. Finally, the mutant mice exhibit behavioral deficits in social interaction and sensorimotor gating. Our results suggest that
an impairment in NR1 phosphorylation leads to glutamatergic hypofunction that can contribute to behavioral deficits associated with
psychiatric disorders.
Introduction
The NMDA type of glutamate receptors plays an essential role in
the induction of synaptic plasticity (Malinow and Malenka,
2002), which is believed to be the cellular mechanism underlying
many forms of adaptive behaviors (Kessels and Malinow, 2009).
Malfunctioning of NMDA receptors (NMDARs), however, has
been implicated in major psychiatric and neurological disorders,
such as schizophrenia and Alzheimer’s disease (Lau and Zukin,
2007).
A prominent hypothesis of schizophrenia invokes hypofunc-
tion of the NMDAR (Coyle et al., 2003; Coyle and Tsai, 2004).
Several lines of evidence support this hypothesis. First, adminis-
tration of noncompetitive NMDAR antagonists, such as phen-
cyclidine or ketamine, to healthy individuals produces the
positive, negative, and cognitive symptoms that mimic schizo-
phrenia, and induces and exacerbates those symptoms in schizo-
phrenia patients (Javitt and Zukin, 1991; Krystal et al., 1994;
Malhotra et al., 1997; Adler et al., 1999; Thaker and Carpenter,
2001; Pietraszek, 2003). Second, results from in vivo brain imag-
ing studies suggest that NMDAR function is decreased in the
brains of schizophrenia patients (Bressan and Pilowsky, 2000;
Millan, 2005; Abbott and Bustillo, 2006; Pilowsky et al., 2006)
(but see Bressan et al., 2005). Third, several studies suggest that
enhancing NMDAR function can alleviate schizophrenic symp-
toms (Matsui et al., 1995; Tsai et al., 1998; Javitt, 2004; Millan,
2005; Coyle, 2006) (but see Tuominen et al., 2005). Last, genetic
studies have identified several schizophrenia-linked genes that
are either directly or indirectly involved in controlling NMDAR
function (Harrison et al., 2003; Harrison and Weinberger, 2005;
Ross et al., 2006). Despite the progress in the field, there has been
inconsistency regarding the nature of NMDAR changes that oc-
cur in schizophrenia (Grimwood et al., 1999; Nudmamud and
Reynolds, 2001; Konradi and Heckers, 2003; Eastwood, 2004;
Beneyto andMeador-Woodruff, 2008). The exact role of NMDAR
dysfunction in the etiology of schizophrenia is also unclear.
TheNMDAR is phosphorylated in the cytoplasmic tail of each
of its subunits, including NR1 and NR2, and phosphorylation of
NMDAR has emerged as an important mechanism regulating its
trafficking and function (Chen and Roche, 2007). The NR1 sub-
unit of NMDARs is phosphorylated at serine 897 by protein ki-
nase A (PKA) (Tingley et al., 1997). In the frontal cortex and
hippocampus of schizophrenia patients, the phosphorylation
level ofNR1 at S897 ismarkedly reduced (Emamian et al., 2004a).
The functional significance of NR1 S897 phosphorylation in vivo
remains elusive.Whether changes inNR1 phosphorylation play a
role in the pathogenesis of schizophrenia or that the decreased
phosphorylation itself is a compensatory response to the chronic
disease is unknown. The main focus of this study is to examine
the physiological and behavioral role of NR1 S897 phosphoryla-
tion in vivo to gain insight into the link between the decreased
phosphorylation at this site and abnormal behaviors.
Materials andMethods
Generation and characterization of S897A NR1 phosphomutant mice. To
construct the targeting vector, a DNA fragment containing the C termi-
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nus of NR1was isolated from the bacterial artificial chromosome library.
Using a PCR strategy, the amino acid serine at position 897 was mutated
to an alanine. A LoxP-FRT-Neo-FRT cassette was inserted into the in-
tron between exon 18 and exon 19 of NR1, and correct orientation was
confirmed by sequencing. Linearized targeting vector was injected into
embryonic stem (ES) cells. In the recombinant ES cells, the FRT-Neo-
FRT cassette was excised using FLP recombinase. Positive ES cell clones
were injected into C57BL/6 blastocysts. The resulting chimeras were
crossed with C57BL/6 mice. Heterozygous mice were bred to produce
homozygotes and wild types (WTs). Successful gene targeting was con-
firmed by sequencing the genomic DNA from the mutant mice. Using a
specific antibody against the phosphorylated NR1 at S897, the deficiency
of NR1 S897 phosphorylation in the mutant mice was confirmed by
Western blot analysis (described below).
Western blot analysis. Tissues from frontal cortex, striatum, or hip-
pocampus of mouse brain (0.05–0.1 g) were homogenized in ice-cold
lysate buffer (0.25 M Tris, pH 7.5) containing protease inhibitors (pro-
tease inhibitor mixture tablets; Roche Diagnostics) and phosphatase in-
hibitors (phosphatase inhibitor mixtures I and II; Sigma-Aldrich) and
were lysed through three cycles of freezing (in liquid nitrogen) and thaw
(in 37°C water bath). Protein concentration was measured (Bio-Rad
protein assay) with spectrometry at 595 nm. Equal amounts of total
proteinwere loaded on 4–12%gradient Bis-Tris gels, separated using the
NuPAGE system (Invitrogen) and transferred onto nitrocellulose mem-
brane. The membrane was probed with primary and secondary antibod-
ies, and signals were detected by chemiluminescence followed by
autoradiography. The following antibodies were used: anti-NR1 (raised
against a conserved sequence of different NR1 splice variants; BD Bio-
sciences Pharmingen andMillipore; 1:1000), anti-GluR1 (Millipore Bio-
science Research Reagents; 1:1000), anti-S897 NR1 (Cell Signaling;
1:500; andMillipore; 1:5000), and anti-postsynaptic density 95 (PSD-95)
(Millipore; 1:2000).
Immunohistochemistry and electron microscopy. Mice were anesthe-
tized and perfused with 4% paraformaldehyde, and brain tissues were
removed and postfixed overnight. Parasagittal brain sections of 60 m
thickness were obtained using a vibratome and were briefly treated with
0.1% glutaraldehyde. Sections were then washed with 0.1 M phosphate
buffer, pH 7.4, and were blocked overnight with 2% normal goat serum.
Sections were incubated for 48 h in blocking solution with 1:400 dilution
of anti-GluR1 antibody (Millipore Bioscience Research Reagents). Sec-
tions were washed four times, 15min each, in 0.1 MTris-saline buffer and
incubated with anti-rabbit secondary antibody (included in the ABC kit;
Vector Laboratories) for 16 h, and were then washed four times, 15 min
each, in Tris-saline buffer. Using the ABC kit (Vector Laboratories), the
brain sections were then subjected to the DAB reaction following the kit
instructions. Electron microscopy analysis was performed following the
methods of Brown and Farquhar (1989). Sections were postfixed and
stained in reduced osmium tetroxide (1% OsO4, 1% potassium ferro-
cyanide, in 0.1 M cacodylate) for 1 h on ice, and were dehydrated through
a graded series of ethanol (50, 70, 95, and 100%). After this step, samples
were treated with 100% propylene oxide for 30 min and infiltrated with
Epon/propylene oxide (1:1) overnight. Samples were treated with two
changes of 100% Epon, 2 h each. Sections were then cured on top of
precured blocks in a 60°C oven for 48 h. Ultrathin sections were cut with
a diamond knife on Ultracut-E (Reichart-Jung) and poststained with
uranyl acetate and lead. Sections were scanned and pictures were taken
on a Tecnai transmission electron microscope (FEI) fitted with Gatan
895 UltraScan digital camera.
Preparation of synaptic-associated proteins. Hippocampi of both brain
hemispheres were dissected and homogenized in 0.5ml of 0.32 M sucrose
supplemented with protease and phosphatase inhibitors. Fifty microli-
ters of each sample was stored, and another 1 ml of sucrose was added to
the rest of each sample. Samples were centrifuged at 800 g for 10 min.
Supernatants were collected and spun at 10,000 g for another 10 min.
The supernatants were stored, and the pellets were resuspended in a
buffer (containing 0.5%TritonX-100, 120mMNaCl, 50mMTris, pH 7.4,
1 mM EDTA plus protease and phosphatase inhibitors). Samples were
incubated on ice for 30 min and spun at 21,000 g for 2 h to isolate the
PSD-95 fraction. Each fractionation experiment was tested by Western
blot analysis of equal amount of proteins from each fraction and probing
with anti-PSD-95 antibody.
Preparation of acute brain slices.Male, 22- to 25-d-old mice were used
for all the electrophysiology experiments. Animals were anesthetized
with isoflurane and decapitated, and the brains were quickly removed
and chilled in ice-cold dissection buffer (110.0mM choline chloride, 25.0
mM NaHCO3, 1.25 mM NaH2PO4, 2.5 mM KCl, 0.5 mM CaCl2, 7.0 mM
MgCl2, 25.0 mM glucose, 11.6 mM ascorbic acid, 3.1 mM pyruvic acid;
gassed with 95% O2/5% CO2). Coronal slices (300 m) were cut in
dissection buffer using a VT-1000 S vibratome (Leica) and subsequently
transferred to a storage chamber containing artificial CSF (ACSF) (118
mM NaCl, 2.5 mM KCl, 26.2 mM NaHCO3, 1 mM NaH2PO4, 20 mM
glucose, 4 mM MgCl2, 4 mM CaCl2; 22–25°C; pH 7.4; gassed with 95%
O2/5%CO2). After at least 1 h of recovery time, slices were transferred to
the recording chamber and were constantly perfused with ACSF main-
tained at 27°C.
Electrophysiology. Experiments were always performed on interleaved
mutant and littermatewild-type animals for comparison. Approximately
two-thirds of the experiments were done blind, which showed the same
results and were combined with the rest of the data. Whole-cell record-
ings were obtained with Axopatch-1D amplifiers (Molecular Devices)
onto pyramidal neurons in the CA1 region of hippocampus under visual
guidance using transmitted light illumination. Synaptic transmission
was evoked with a bipolar stimulating electrode placed in the Schaffer
collateral pathway, 0.2 mm away from cell bodies. Responses were
recorded at holding potentials of both 60 mV (for AMPA receptor-
mediated responses) and 40 mV (for NMDAR-mediated responses).
NMDA receptor-mediated responses were quantified as the mean be-
tween 110 and 160 ms after stimulation. Bathing solution (ACSF) con-
tained the following (in mM): 119 NaCl, 2.5 KCl, 4 CaCl2, 4 MgCl2, 26.2
NaHCO3, 1 NaH2PO4, 11 glucose, 0.1 picrotoxin, and gassed with 5%
CO2 and 95% O2 at 27°C. Internal solution contained the following (in
mM): 115 cesium methanesulfonate, 20 CsCl, 10 HEPES, 2.5 MgCl2, 4
Na2-ATP, 0.4 Na-GTP, 10 Na-phosphocreatine, and 0.6 EGTA, pH 7.2.
Spontaneous responses [miniature EPSCs (mEPSCs)] were recorded at
27°C in the presence of 1 M TTX and 0.1 mM picrotoxin and analyzed
using Mini Analysis Program (Synaptosoft). For recordings on mEPSC
or field EPSPs, the concentration for Ca2 and Mg2 were adjusted to
2.5 and 1.3 mM, respectively. Electrodes (1 m) were filled with 1 M
NaCl and placed in the dendritic area (0.25 mm from the somas in
CA1) to record field EPSPs. Long-term potentiation (LTP) was induced
by stimulating the Schaffer–collateral pathway (two trains of 1 s pulses at
100 Hz, at an interval of 25 s). The result of the LTP experiments was
displayed as EPSP amplitude normalized to the average of the responses
before LTP induction.
Animals for the behavioral assays. A total of eight male homozygous
phosphomutant mice and eight of their wild-type littermates were
tested for social interaction, and 10 pairs of homozygous mutants and
their wild-type littermates were studied for prepulse inhibition. Adult
(6 –12 weeks) male cohorts of paired homozygous and their wild-type
littermates (with similar body weight) were used for the behavioral
assays of this study. Mice were housed individually and were main-
tained on a 12 h light/dark cycle with light on at 6:00 P.M. All animals
had food and water available ad libitum and were cared for in accor-
dance with the Rockefeller University Institutional Animal Care and
Use Committee protocol.
Social interaction. The social interaction paradigm was used as previ-
ously described (Choleris et al., 2003). Briefly, a stimulus mouse was
presented to an experimental mouse in its home cage, which was covered
with a clear Plexiglas top (23 33 cm). The stimulus mouse was placed
in a clear Plexiglas cylinder (9 cm in diameter, 10 cm in height) with 20
holes (4 mm diameter) drilled near the bottom of the cylinder to allow
the passage of olfactory cues while preventing direct interaction between
the experimental and the stimulus mouse. All tests were done at the dark
phase of the light/dark regimen. Before testing, all mice were moved to
the darkened testing room with a small red light, and experimental mice
were habituated to the presence of an empty cylinder in their home cage
for 10 min. Similarly, the stimulus mice were also placed in the clear
cylinders and habituated for 5 min before testing. Each experimental
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mouse was tested five times (tests 1–5) in their home cage, in which a
cylinder containing a stimulus mouse was introduced. Each test lasted 5
min, with 15 min intervals in between. In tests 1–4, the same stimulus
mouse was used, whereas in test 5, a novel stimulus mouse was used.
During testing, mice were left undisturbed in the room and their behav-
ior was videotaped (8 mm Canon Handycam) for subsequent analysis.
During the 15min intertest intervals, the same empty cylinderwas placed
back in the cage. The position of all the cylinders introduced into the
mouse home cage was kept constant throughout the experiment. After
every use, cylinders were thoroughly washed with unscented soap and
then dried by paper towel. The behavioral data collected include social
investigation (active sniffing of the holes) and rearing (not in relation to
the cylinder).
Animals’ olfactory functionwas examined tomake sure that the deficit
in social behavior of the NR1 S897A mutant animals was not caused by
changes in the olfactory system. An olfactory stimulus, which was the
odor from 100% benzaldehyde solution (Sigma-Aldrich), was presented
for a 20 s duration when mice were in a “resting state” (i.e., there was no
home cage activity detected by the computer [i.e., the total distance (TD)
traveled, horizontal activity (HA), and vertical activity (VA) were zero])
for at least 5 min. The changes in the animals’ home cage activity (TD,
HA, and VA) were measured until the animals reached the resting state
again (10 min).
Prepulse inhibition of the acoustic startle response. Prepulse inhibition
(PPI) of the acoustic startle response was measured as described previ-
ously with some minor modifications (Emamian et al., 2004b). Adult
homozygous mutant mice and their wild-type littermates were housed
individually for 2 weeks before testing. Testing was conducted in a
SR-Lab system (SanDiego Instruments). Response amplitude was calculated
as the maximum response level that occurred during the 100 ms record-
ing. Because animals can habituate to the prepulse, and to the startle
stimulus, the number of trials was kept to minimum. Immediately after
being placed in the chamber, the animal was allowed to acclimate for 5
minwith backgroundnoise (86 dB) continually present. The animal then
received 10 sets of the following five types of trials, distributed pseudo-
randomly, and separated by 15 s intertrial intervals: trial 1, 40ms, 120 dB
noise burst alone; trials 2–4, 120 dB startle stimuli preceded 100 ms by
one of the three 20 ms prepulses: 90, 94, or 98 dB; trial 5, no-stimulus/
background noise alone (86 dB). As a control experiment to examine the
efficacy of PPI protocol used in this study, wild-type C57BL/6 mice were
injected with ()-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-
5,10-imine maleate (MK-801) [1 mg/kg; using the methods of Yee et al.
(2004)] and subjected to the same PPI protocol described here. This
control experiment showed that injection ofMK-801 resulted in a signif-
icant decrease in PPI (data not shown) using this PPI protocol. Data were
analyzed using ANOVA with repeated measures.
Results
To investigate directly the physiological and behavioral role of
NR1 S897 phosphorylation in vivo, we generated a knock-in
mouse in which the serine 897 of NR1 is substituted with an
alanine (Fig. 1A) (see Materials and Methods), thereby prevent-
ing its phosphorylation. We confirmed that the mutant mice
carry the point mutation in its genome (Fig. 1B) and express the
full-length NR1 protein at a level comparable with the wild-type
mice (Fig. 1C), and the phosphorylation of NR1 at S897 is pre-
cluded because of the mutation to alanine (Fig. 1C).
To examine the effects of NR1 S897 phosphomutation on
synaptic function, we recorded both NMDAR- and AMPAR-
mediated synaptic transmission in the Schaffer collateral–CA1
synapses in the hippocampi of S897A mutant mice. Compared
with wild-type animals, the ratio of NMDAR- to AMPAR-
mediated synaptic transmission was markedly reduced in the
mutant animals (Fig. 2A) (WT, 0.82 0.14, n 10;mutantmice,
0.31 0.04, n 12; p 0.01). The decrease inNMDA-to-AMPA
ratio could be attributable to either a decrease of NMDAR- or an
increase in AMPAR-mediated synaptic transmission. To distin-
guish between these possibilities, we recorded AMPAR-mediated
mEPSCs from CA1 pyramidal neurons in the hippocampus. We
found that both the amplitude (Fig. 2B) [WT, 13.5 0.2 pA, n
1138 events from 10 cells; mutant mice, 12.4 0.2 pA, n 662
events from 10 cells; p  0.01 by Kolmogorov–Smirnov (K–S)
test] and the frequency (Fig. 2B) (WT, 13.8 2.1 permin, n 10
cells; mutant, 8.5  1.4 per min, n  10 cells; p  0.05) of the
AMPAR-mediated mEPSCs were decreased in the mutant ani-
mals. As expected, the interevent intervals of mEPSCs from the
mutant animals were longer (Fig. 2C) ( p 0.01 byK–S test). The
reduction of mEPSC frequency likely reflects a decrease in
the number of functional synapses that contain AMPARs,
whereas the decrease inmEPSC amplitude is likely attributable to
a reduction in the number of AMPARs per synapse. These results
demonstrate that both NMDAR- and AMPAR-mediated synap-
tic transmission onto CA1 cells are reduced. The reduction of
NMDA-to-AMPA ratio indicates that the reduction of NMDA
transmission is more dramatic than that of AMPA. As expected,
given the important role of NMDARs in the induction of LTP,
LTP in the Schaffer collateral–CA1 pathway was impaired in the
mutantmice (Fig. 2D) (n 13 for bothWT andmutant animals;
p  0.05). These results indicate a severe impairment of
NMDAR-mediated synaptic transmission in themutant animals,
leading to decreased synaptic plasticity and AMPAR-mediated
synaptic transmission. Since both AMPAR- and NMDAR-
mediated synaptic transmission are markedly impaired, the defi-
ciency of LTP in the mutant animals could be because there is
insufficient activation of NMDARs (because of the impairment
in AMPAR-mediated synaptic transmission) or insufficient
number of NMDARs.
Figure 1. Genetic blockade of NR1 S897 phosphorylation.A, Schematic view of the targeting vector generated for targeting the S897 site of GRIN1 locus of themouse genome (seeMaterials and
Methods). B, Confirmation of gene targeting in the genomic DNA of the mutant mice by sequencing using a specific primer close to this site. C, Western blot analysis to confirm the absence of
phosphorylation at S897 in the S897Amutant animals using the NR1 S897 phosphospecific antibody. Total protein extracts of 50g from the frontal cortex (FC), striatum (STR), and hippocampus
(HIP) of the WT animals and homozygous mutants were loaded. Top blot, Anti-NR1 S897; middle blot, anti-NR1; bottom blot, anti-actin.
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To determine whether the decreased
NMDAR-mediated synaptic transmission
is caused by a deficit in NR1 synaptic
incorporation in the S897A mutant
mice, we prepared synaptic membrane-
associated proteins by biochemical frac-
tionation of hippocampal tissue dissected
from either the wild-type or the mutant
mice. The mutant mice showed a signifi-
cant decrease in NR1 protein level only in
the synaptic fraction (Fig. 3A), whereas
NR1 level in the total brain homogenate
was unchanged (Fig. 1C, representative
blot). Moreover, GluR1 protein level in
the synaptic faction (Fig. 3A), but not in
the total homogenate (data not shown), is
also significantly reduced in the mutant
animals, consistent with the impairment
in AMPAR-mediated synaptic transmis-
sion (Fig. 2). GluR1-containing AMPAR
synaptic insertion requires NMDAR acti-
vation (Shi et al., 1999), which underlies
LTP in the Schafer collateral–CA1 syn-
apses (Malinow and Malenka, 2002). We
therefore also examined the localization
of GluR1 in the dendritic spines in the
CA1 area of the hippocampus by electron
microscopy after immunostaining with a
specific antibody against GluR1. Strik-
ingly, unlike the wild-type mice, which
showed strong GluR1 immunoreactivity
in the PSD region, mutant animals had
markedly reduced GluR1 staining near
the PSD regions and often formed abnor-
mal clusters within the dendritic spines
(Fig. 3B). Quantification of the total num-
ber of synapses that positively stainedwith
GluR1 indicates a highly significant de-
crease in the number of GluR1-positive
synapses in the mutant animals ( p 
0.0001 by t test) (Fig. 3B). These data suggest that preventingNR1
S897 phosphorylation caused severe impairment in synaptic
NMDAR function such that it is not sufficient to drive effectively
GluR1 into the synapse during synaptic plasticity, as evidenced by
the reduction in basal synaptic transmission (Fig. 2A–C) and
impairment in LTP in the mutant animals (Fig. 2D).
Since the S897A mutation caused severe impairments in glu-
tamatergic synaptic function and plasticity, wewonderedwhether it
could also lead to behavioral deficits. To test this, we examined the
mutant mice with behavioral assays commonly used to examine
behavioral deficits in rodent models of schizophrenia. We first ex-
amined the animal’s home cage motor activity and found that,
across all the parameters measured (horizontal/vertical activity
and total distance traveled), there was no significant difference
between the homozygous mutant animals and their wild-type
littermates (data not shown), suggesting that the S897Amutation
does not affect the overall motor function.
To test whether the phosphomutant animals exhibit deficits in
social interaction, we used an assay that examines the social in-
terest in rodents while minimizing the variability that can be
introduced by different intruders in a typical social interaction
assay based on intruder mice (Choleris et al., 2003). In this assay,
each experimental mouse was tested five times (tests 1–5) for its
reaction to a cylinder containing a stimulus mouse. In tests 1–4,
the same stimulus mouse was used, whereas in test 5 a novel
stimulus mouse was introduced. The behavioral data collected
included social investigation (active sniffing of the holes near the
bottom of the cylinder) and rearing (not in relation to the cylin-
der). The wild-type mice showed the expected decrease in social
response (habituation to the stimulus mouse) throughout tests
1–4 (comparison between tests 1 vs 4, p  0.001; N  8) (Fig.
4A). The wild-type mice also showed the expected increase in
social interest when presented with a novel animal at test 5 (com-
parison between test 4 vs test 5, p  0.001; N  8) (Fig. 4A).
However, the mutant mice did not show the expected decline in
the number of social investigations toward the repeatedly intro-
duced stimulus mouse (comparison between tests 1 vs 4, p 	
0.05; N  8) (Fig. 4A), and also failed to show the expected
increase in social investigation toward the novel stimulus mouse
(comparison between tests 4 vs 5, p 	 0.05; N  8) (Fig. 4A).
Analysis of the frequency of vertical activity (rearing) showed that
the mutant mice exhibited significantly less number of rearing
compared with their wild-type littermates in test 1 (Fig. 4B).
However, in tests 2–5, the difference in vertical activity between
mutant and wild-type mice was not significant (Fig. 4B). The
difference in test 1 but not in tests 2–5 could be attributable to a
Figure 2. The NR1 S897Amutation depressed synaptic transmission and reduced LTP. A, The top panel shows the representa-
tive traces of evokedEPSCs recorded fromCA1neurons in eitherWTormutanthippocampal slices. EPSCs atboth60and40mV
holding potentials are shown. Calibration: 50 ms, 20 pA. The bottom histogram is the quantification of the ratio of NMDAR- to
AMPAR-mediated synaptic transmission for WT andmutant animals (WT, 0.82 0.14, n 10; mutant mice, 0.31 0.04, n
12; **p 0.01, t test). B, Representative traces of AMPAR-mediated mEPSCs recorded from slices of WT (left) or mutant (right)
animals. Calibration: 500 ms, 20 pA. Quantification of the amplitude of AMPAR-mediated mEPSCs for WT and mutant animals is
described here (WT, 13.5 0.2 pA, n 1138 events from 10 cells; mutant mice, 12.4 0.2 pA, n 662 events from 10 cells;
**p 0.01, K–S test). Quantification of the frequency of AMPAR-mediatedmEPSCs forWT andmutant animals is described here
(WT, 13.8 2.1 per min, n 10 cells; mutant, 8.5 1.4 per min, n 10 cells; *p 0.05, t test). C, Cumulative distribution of
the interevent intervals of the mEPSCs fromWT and mutant animals (WT, n 1138 events from 10 cells; mutant mice, n 662
events from10 cells;p0.01, K–S test).D, Toppanel, Representative traces of field EPSPs (fEPSPs) fromWTormutant hippocam-
pal slices. Traces are averaged for time points before (1) and after (2) LTP induction. Calibration: 200 ms, 0.1 mV. Bottom panel,
Normalized amplitudes of fEPSPs before and after delivery of the LTP-induction stimuli (arrow). N 13 for both WT and mutant
animals; *p 0.05. Error bars indicate SEM.
11968 • J. Neurosci., September 23, 2009 • 29(38):11965–11972 Li et al. • NR1 Phosphorylation and Synaptic and Behavioral Plasticity
difference between the wild-type andmutant mice in response to
a novel environment. To test whether the deficit in social behavior
of theNR1S897Amutant animals could be explainedby a change in
olfactory function, we examined the mice for olfactory responsive-
ness and found that themutantmice showednormal response to an
olfactory stimulus,whichwasmeasured as the response to the odor
of an 100% benzaldehyde solution presented when themice were
in resting state (see Materials and Methods) (data not shown).
These results demonstrate that the NR1 S897Amutation impairs
the function of the brain system that underlies normal social
behaviors.
Schizophrenia patients show sensorimotor gating deficits that
can be measured as an impairment in PPI, in which a weak audi-
tory prestimulus or prepulse reduces the startle response to a
subsequent intense auditory stimulus (Javitt et al., 2008). Abnor-
mal PPI has also been used as an indicator of impaired sensori-
motor gating in rodent models of schizophrenia (Swerdlow and
Geyer, 1998; Geyer et al., 2002). To determine whether the S897A
mutation could affect sensorimotor gating, we examined PPI in
the phosphomutant animals and their wild-type littermates. We
used a combination of one startle stimulus (120 dBA) preceded by
one of the three prepulse stimuli of different intensities (4,8,
and 12 dBA above the background noise). As shown in Figure
4C, the phosphomutant animals showed significantly decreased
PPI for prepulse intensities of 8 or 12 dBA above the background
noise (at8 dBA, p 0.05, N 10; at12 dBA, p 0.05, N
10). We also evaluated the amplitude of the baseline acoustic
startle response (in the absence of prepulses). There was no sig-
nificant difference in the startle response amplitude between the
mutant and wild-type animals. These results demonstrate that
Figure 3. The NR1 S897A mutation decreased synaptic incorporation of glutamate receptors and reduced GluR1 in the synapse. A, Left, Western blot analysis after biochemical fractionation of
hippocampal tissues dissected fromWT and the homozygous mutant mice. Synaptic membrane-associated proteins (10g) were loaded, and the same blot was probed with antibodies against
GluR1 (top), NR1 (middle), and PSD-95 (bottom). Right, Quantification of the densities of total synaptic GluR1 (top) and NR1 (bottom) signals fromWT (n 3) and the homozygous mutant (n
3)mice. Error bars indicate SEM (*p 0.05, t test).B, Immuno-EManalysis of the CA1 regions of the hippocampus fromWT andmutantmice. Left panel, No primary antibody controls; right panels,
top, three representative EM fields of the CA1 regions of wild-type animals thatwere probedwith an anti-GluR1 antibody. The dark black staining of GluR1 in postsynaptic areas is the specific GluR1
signal, which is absent in the sections thatwere probedwith the secondary antibody alone (no primary antibody control; on the left). Right panels, Bottom, Three representative EM fields of the CA1
regions of the homozygousmutant mice probedwith the anti-GluR1 antibody. The dark black staining shows themislocalized clusters of GluR1 signal. This signal is specific as it is absent in control
sections (probed with the secondary antibody alone; on the left). Quantification of the number of GluR1-positive synapses in each EM field (2m2) in the CA1 regions of the wild-type mice and
homozygous mutant mice shows a highly significant decrease in the number of GluR1-positive synapses in mutants (p 0.0001, t test; N 9 for both groups). Scale bars, 200 nm.
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the NR1 S897A mutation impairs the plasticity of the startle re-
sponse (i.e., PPI), while leaving the sensory responsiveness intact,
and indicate that NR1 S897 phosphorylation plays a critical role
in regulating the function of the neural circuitry underlying sen-
sorimotor gating.
Discussion
In this study, we found that preventing NR1 S897 phosphoryla-
tion in vivo by substituting serine with alanine in mice severely
reduces the level and function of NMDARs in the synapse, im-
pairs synaptic plasticity and GluR1 synaptic incorporation, and
impairs AMPAR-mediated synaptic transmission. Furthermore,
the phosphomutant mice also show deficits in social activities
and sensorimotor gating.
Previous studies in cell cultures showed that overexpressed
NR1 subunits are retained in the endoplasmic reticulum (ER)
because of an ER retention signal near S897 (Standley et al.,
2000), andmutations that mimic S897 phosphorylation can sup-
press the ER retention and facilitate NR1 exiting from ER,
thereby regulating the level ofNMDARs on cell surface (Xia et al.,
2001; Scott et al., 2003). Therefore the impairment in NR1 syn-
aptic incorporation in the phosphomutant animals could be at-
tributable to a failure in phosphorylatingNR1 S897 and increased
NR1 ER retention. However, ER retention of wild-type NR1 is
relieved when it is coexpressed with NR2 subunits (Barria and
Malinow, 2002). Since mutant animals express NR1 (Fig. 1C)
and NR2 subunits (data not shown) at levels similar to those of
wild-type animals, the amount of fully assembled NMDARs
that can exit ER in the mutant animals may be comparable
with that of wild-type animals. Therefore, the reduction of
synaptic NMDARs in the NR1 phosphomutant animals could be
attributable to an impairment downstream of ER retention, such
as faulty NMDAR synaptic incorporation.
The reduction of AMPA currents andAMPAR synaptic incor-
poration in the mutant animals could be caused by the primary
impairment in NMDAR-mediated synaptic transmission, since
NMDARs are essential for both synaptic maturation and plastic-
ity (Constantine-Paton and Cline, 1998). Interestingly, recent
studies showed that complete deletion of NR1 (Adesnik et al.,
2008; Engblom et al., 2008; Zweifel et al., 2008) or NR2B (Hall et
al., 2007) results in potentiation of AMPAR-mediated synaptic
transmission. It is possible that low levels of NMDAR function
during development act to reduce synaptic AMPAR levels (Sheng
and Kim, 2002). The NR1 S897 mutation, which produces low
levels of NMDAR function, could enhance this effect. The com-
plete loss of NMDAR function during early development, as
achieved by genetic deletion of either NR1 (Adesnik et al., 2008;
Engblom et al., 2008; Zweifel et al., 2008) or NR2B (Hall et al.,
2007), prevents this normally occurring reduction, leading to a
net potentiation of AMPAR transmission. Alternatively, changes
in signaling pathways that are normally coupled to NMDAR via
NR1 phosphorylation could account for the synaptic depression
in the NR1 S897Amutant animals. Additional studies are needed
to clarify these issues.
Social behavior and sensorimotor gating are impaired in both
schizophrenia patients and rodent models of schizophrenia. In
this study, we found that the NR1 S897A mutant mice display
significant impairments in social behaviors and sensorimotor
gating, as measured by a social interaction paradigm and PPI,
respectively. Notably, social abnormalities and PPI deficit similar
to those that we observed in the NR1 S897 phosphomutant mice
can also be induced in rodents by NMDAR antagonists such as
phencyclidine, MK-801, and ketamine (Swerdlow and Geyer,
Figure 4. The NR1 S897Amutation causes behavioral deficits. A, B, Social interaction of
the experimental mice toward the repetitively presented stimulus mouse (tests 1– 4), or
a novel stimulus mouse (test 5). Mutant, NR1 S897A homozygous mutant mice; WT,
wild-type littermates. A, Quantification of active social investigation: number of sniffs;
N 8 for both groups. One-way repeated-measures ANOVA was used to evaluate recog-
nition memory in WT and mutant mice. Significance ( ***p  0.0001; F  8.3) was
further evaluated using Bonferroni’s multiple-comparison post hoc test. In test 5, in which
a new intruder was introduced,WTmice showed increased recognitionmemory compared
with mutant mice ( p 0.001; t 5.728). WT mice also showed statistically decreased
exploration toward the same intruder through tests 1– 4 ( p 0.01, t 4.226, test 1 vs
test 2; p 0.001, t 5.449, test 1 vs test 3; and p 0.001, t 5.708, test 1 vs test 4),
whereas there was no significant difference when compared test 1 (the very first presen-
tation of the intruder, which was presented repeatedly in tests 1– 4) with test 5 (the new
intruder). In contrary to WT mice, mutant mice did not show recognition memory
throughout tests 1–5. B, Quantification of the activity in exploring the cage away from
social interest: number of rears (not in relation to the cylinder); N 8 for both groups.
Compared with mutant mice, WT mice littermate exhibited significantly higher explor-
atory activity in test 1 ( p 0.01; t 3.4). C, Prepulse inhibition of NR1 S897A phospho-
mutant mice andWT littermate controls. PPI was expressed as 100 [(response to startle
stimulus after prepulse/response to startle stimulus alone) 100]. *p 0.05; N 10 for
both groups. Error bars indicate SEM.
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1998; Ellenbroek andCools, 2000; Geyer et al., 2001, 2002; Powell
and Miyakawa, 2006). However, neither of the two behavioral
phenotypes we observed in the mutant mice is specific to schizo-
phrenia. For example, social interaction deficits can be seen in
autism (Moy and Nadler, 2008), and PPI deficits can be seen in
other disorders as well (Giakoumaki et al., 2007). Furthermore, it
is difficult to draw an analogy between rodent social behaviors,
which are primarily driven by olfactory function, with those of
humans. Additional studies, including a comprehensive battery
of behavioral tests that examine different aspects of cognitive
function, are necessary to determine whether this mutation can
cause specific cognitive deficits in rodents that are related to
schizophrenia or other psychiatric or neurological disorders.
There are several scenarios that can explain how a decrease
in NR1 S897 phosphorylation could contribute to abnormal
behavior. A decrease in NMDAR function, such as that caused
by genetic deficits (Stefansson et al., 2002; Li et al., 2007) or
pharmacological treatments (Xu et al., 2006; Mouri et al., 2007;
Snyder et al., 2007), may lead to inefficient phosphorylation of
NR1 at S897, which further impairs NMDAR function, resulting
in a positive-feedback-likemechanism. This will result in impair-
ments in synaptic function and plasticity, and abnormal behav-
iors. Alternatively, since NR1 S897 is phosphorylated by PKA
(Tingley et al., 1997), a primary change in PKA or a phosphatase
(such as calcineurin) activity could also lead to changes in S897
phosphorylation. Interestingly, both PKA pathway and cal-
cineurin have been linked to schizophrenia (Sawa and Snyder,
2005; Horiuchi et al., 2007; Kinoshita et al., 2008).
The findings of our study provide new insight for the mecha-
nisms by which NMDAR hypofunction could occur. The NR1
S897A mice therefore can serve as a genetic tool for additional
circuit and behavioral analysis.
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